These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7980599)

  • 1. Demonstration of derivation of rat urinary bradykinin from plasma low-molecular-weight kininogen: a study using kininogen-deficient rats.
    Hagiwara Y; Kojima M; Hayashi I; Oh-ishi S
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1219-24. PubMed ID: 7980599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of kinin fractions in ureter urine and bladder urine of normal and kininogen-deficient rats.
    Yamasu A; Oh-ishi S; Hayashi I; Hayashi K; Hayashi M; Yamaki K; Nakano T; Sunahara N
    J Pharmacobiodyn; 1989 May; 12(5):287-92. PubMed ID: 2681678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of the third kininogen in high and low molecular weight kininogens-deficient Brown Norway Katholiek rat.
    Hayashi I; Ino T; Kato H; Iwanaga S; Nakano T; Oh-ishi S
    Thromb Res; 1984 Dec; 36(6):509-16. PubMed ID: 6570369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed.
    Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J
    Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of T-kininogen in high and low molecular weight kininogens deficient rat (brown Norway Katholiek strain).
    Hayashi I; Oh-ishi S; Kato H; Enjyoji K; Iwanaga S; Nakano T
    Thromb Res; 1985 Aug; 39(3):313-21. PubMed ID: 3850646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of kallikrein-kinin system in acute inflammation: studies on high- and low-molecular weight kininogens-deficient rats (B/N-Katholiek strain).
    Oh-ishi S; Hayashi I; Utsunomiya I; Hayashi M; Yamaki K; Yamasu A; Nakano T
    Agents Actions; 1987 Aug; 21(3-4):384-6. PubMed ID: 3687591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats.
    Majima M; Yoshida O; Mihara H; Muto T; Mizogami S; Kuribayashi Y; Katori M; Oh-ishi S
    Hypertension; 1993 Nov; 22(5):705-14. PubMed ID: 7693588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionally active high molecular weight-kininogen was found in the liver, but not in the plasma of brown Norway Katholiek rat.
    Hayashi I; Maruhashi J; Oh-ishi S
    Thromb Res; 1989 Oct; 56(2):179-89. PubMed ID: 2617467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and properties of two rat plasma T-kininogens.
    Okamoto H; Greenbaum LM
    Adv Exp Med Biol; 1986; 198 Pt A():69-75. PubMed ID: 3544720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of two kinds of low molecular weight kininogens from rat (non-inflamed) plasma. One resistant and the second sensitive to rat glandular kallikreins.
    Enjyoji K; Kato H; Hayashi I; Oh-ishi S; Iwanaga S
    J Biol Chem; 1988 Jan; 263(2):965-72. PubMed ID: 3335530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.
    Kato H; Enjyoji K; Miyata T; Hayashi I; Oh-ishi S; Iwanaga S
    Biochem Biophys Res Commun; 1985 Feb; 127(1):289-95. PubMed ID: 3844939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of monoclonal antibodies against rat plasma kallikrein, rat low molecular weight kininogen and synthetic bradykinin.
    Bedi GS; Back N
    Adv Exp Med Biol; 1989; 247B():223-30. PubMed ID: 2610064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological regulation by the kallikrein-kinin system: a study with a kininogen-deficient rat strain].
    Oh-Ishi S
    Nihon Yakurigaku Zasshi; 1993 Apr; 101(4):209-18. PubMed ID: 8514206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of urinary kininogenase activity using bovine serum low molecular weight kininogen.
    Abe K; Kato H; Sakurai Y; Itoh T; Saito K; Haruyama T; Otsuka Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120A():105-14. PubMed ID: 495304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fujiwara trait: the first case of kininogen deficiency in Japan.
    Oh-Ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Adv Exp Med Biol; 1979; 120B():93-9. PubMed ID: 517263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinin released from high molecular weight-kininogen is responsible for inflammatory exudation in rats: detection of kinin-free-kininogen in the exudate by immunoblot analysis.
    Fujie H; Hayashi I; Oh-ishi S
    Life Sci; 1993; 53(22):1691-701. PubMed ID: 8231650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new kinin in human urine.
    Mindroiu T; Scicli G; Perini F; Carretero OA; Scicli AG
    J Biol Chem; 1986 Jun; 261(16):7407-11. PubMed ID: 3635531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of rat low molecular weight kininogen.
    Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O; Handa H
    J Biochem; 1984 Jul; 96(1):81-8. PubMed ID: 6238024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats.
    Majima M; Mizogami S; Kuribayashi Y; Katori M; Oh-ishi S
    Hypertension; 1994 Jul; 24(1):111-9. PubMed ID: 8020999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.